Mapping brain metals to evaluate therapies for neurodegenerative disease.
about
Zinc-mediated Allosteric Inhibition of Caspase-6Synchrotron radiation X-ray microfluorescence reveals polarized distribution of atomic elements during differentiation of pluripotent stem cellsElemental and chemically specific X-ray fluorescence imaging of biological systemsTrace elements during primordial plexiform network formation in human cerebral organoidsPathogenic implications of distinct patterns of iron and zinc in chronic MS lesionsRole of metal dyshomeostasis in Alzheimer's disease.Changes of ferrous iron and its transporters after intracerebral hemorrhage in ratsProlonged therapeutic hypothermia does not adversely impact neuroplasticity after global ischemia in ratsImaging of stroke: a comparison between X-ray fluorescence and magnetic resonance imaging methods.Ferric iron chelation lowers brain iron levels after intracerebral hemorrhage in rats but does not improve outcome.A novel approach to quantify different iron forms in ex-vivo human brain tissue.Targeting metabolic inflammation in Parkinson's disease: implications for prospective therapeutic strategies.Inhibitory effects of NAMI-A-like ruthenium complexes on prion neuropeptide fibril formation.The molecular basis of memory.Flow of essential elements in subcellular fractions during oxidative stress.Metallo-pathways to Alzheimer's disease: lessons from genetic disorders of copper trafficking.Distribution and chemical forms of gadolinium in the brain: a review.Collateral circulation prevents masticatory muscle impairment in rat middle cerebral artery occlusion model.Differences in iron and manganese concentration may confound the measurement of myelin from R1 and R2 relaxation rates in studies of dysmyelination.
P2860
Q27671521-68AF82D4-C8E7-4D4D-B778-9E896FA80A29Q28478462-5355CDCC-1616-488C-80D4-DDA810F74EA1Q28655858-5D5C99D5-516C-404E-B6AE-3685DC54FC7CQ28973587-7BB07B8C-2623-4B7B-A35B-F36775291731Q33841090-5B71824B-B840-4F46-81C3-2BFB16015E33Q35051952-6A757569-F8FB-4250-9430-FF3B0988313EQ35855250-A506BFD0-0DB3-4559-AD60-D1A151B1868FQ36170320-A3973455-FD3E-474A-9942-0F2A5B19D265Q37348780-31348145-9153-4927-A855-55A1A6AE86B7Q37360337-E23A1AC2-37EB-4E74-86CB-C291B95C69C4Q37493964-83D9DF7A-28A4-49B2-8934-152CF7CF0BBBQ37962621-497B98D0-6D80-4ADE-B018-05D818DB0F6FQ42174365-145F4F96-9FC1-4E88-B657-FD4D8DA10656Q42504970-CFA3240B-5843-4959-9478-B54032998717Q47591045-FD15FC8C-A565-46C5-A7F6-7DE0D60446D3Q47985612-8D24B63C-1220-447A-989F-C0D5DAD2F365Q48177361-EDB4EB4B-C94A-482B-B13B-FA61B0FF3954Q48475787-016E2A4C-1140-45FE-BCF1-73D4B315C72EQ48713239-9B0CA6AE-3373-4E42-99B7-57C7DE7A365C
P2860
Mapping brain metals to evaluate therapies for neurodegenerative disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mapping brain metals to evaluate therapies for neurodegenerative disease.
@en
Mapping brain metals to evaluate therapies for neurodegenerative disease.
@nl
type
label
Mapping brain metals to evaluate therapies for neurodegenerative disease.
@en
Mapping brain metals to evaluate therapies for neurodegenerative disease.
@nl
prefLabel
Mapping brain metals to evaluate therapies for neurodegenerative disease.
@en
Mapping brain metals to evaluate therapies for neurodegenerative disease.
@nl
P2860
P1476
Mapping brain metals to evaluate therapies for neurodegenerative disease.
@en
P2093
Bogdan Florin Gh Popescu
Helen Nichol
P2860
P304
P356
10.1111/J.1755-5949.2010.00149.X
P577
2010-06-14T00:00:00Z